Tag: Anti angiogenesis

Approximately 80% of cancer treatments involve a combination of therapies. Versavo 400, a biosimilar of bevacizumab, is a targeted anti-cancer drug used in combination with other chemotherapy drugs for treating several types of advanced cancers.

First approved in 2004, Avastin was the first therapy designed to inhibit angiogenesis, or the formation of new blood vessels, that became available in the United States [1.4.2, 1.6.1]. So, **what is AVA medication**? In oncology, it often refers to Avastin (bevacizumab), a targeted therapy used to treat many types of cancer [1.3.2].